A Novel SS18-SSX Fusion-specific Antibody for the Diagnosis of Synovial Sarcoma

Overview of attention for article published in The American Journal of Surgical Pathology, March 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#22 of 4,469)
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

twitter: 96 X users
wikipedia: 1 Wikipedia page

guideline: 1 clinical guideline source
bluesky: 2 Bluesky users

Readers on

mendeley: 95 Mendeley

So far, Altmetric has seen 4 Bluesky posts from 2 Bluesky users, with an upper bound of 1,128 followers.

RP @folpe-mn-st.bsky.social: It’s diffusely positive for SS18-SSX fusion protein and SSX c-terminus antibody. Monophasic synovial sarcoma, with nuclear palisading. Yes, I’ve seen this before. No, not anywhere near this much. pubmed.ncbi.nlm.nih.gov/321418…

It’s diffusely positive for SS18-SSX fusion protein and SSX c-terminus antibody. Monophasic synovial sarcoma, with nuclear palisading. Yes, I’ve seen this before. No, not anywhere near this much. pubmed.ncbi.nlm.nih.gov/32141887/

RP @folpe-mn-st.bsky.social: pubmed.ncbi.nlm.nih.gov/32141887/

pubmed.ncbi.nlm.nih.gov/32141887/

This page shows the most recent Bluesky posts that mention this research output. Click here to find out how to access more activity.